abnormal osteoclast physiology_Mepe<tm1Tbrw>/Mepe<tm1Tbrw>

http://metadb.riken.jp/0001541I129P2OlaHsdC57BL6Mepetm1TbrwMepetm1TbrwMepetm1Tbrw

abnormal osteoclast physiology_Mepe<tm1Tbrw>/Mepe<tm1Tbrw>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• matrix extracellular phosphoglycoprotein with ASARM motif (bone)
  http://metadb.riken.jp/db/mgi_rdf/MGI:2137384

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Mepe<tm1Tbrw>/Mepe<tm1Tbrw>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Mepe<tm1Tbrw>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal osteoclast physiology
  http://purl.obolibrary.org/obo/MP_0001541

文献

http://purl.org/net/cito/citesAsAuthority

• Lori C. Gowen, et.al., Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass., The Journal of biological chemistry, 2003, 278
  http://rdf.ncbi.nlm.nih.gov/pubmed/12421822